Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Key developments in non-metastatic and metastatic hormone-sensitive prostate...
Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria...
Key developments in non-metastatic and metastatic hormone-sensitive prostate cancer ( Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De Santis )
4 Jun 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
21 May 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018
Expert insight: Metastatic hormone sensitive prostate cancer latest
Professor Karim Fizazi and Professor Nicholas James
Expert insight: Metastatic hormone sensitive prostate cancer latest ( Professor Karim Fizazi and Professor Nicholas James )
10 Feb 2018
Focus on non-metastatic castration resistant prostate cancer
Professor Noel Clarke and Dr Eric Small
Focus on non-metastatic castration resistant prostate cancer ( Professor Noel Clarke and Dr Eric Small )
10 Feb 2018
The best sequence of anti-HER2 therapy in metastatic breast cancer
Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain
The best sequence of anti-HER2 therapy in metastatic breast cancer ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )
29 Jan 2018
ESO-ESMO-ABC guidelines in metastatic breast cancer
Dr Nagi El Saghir - American University of Beirut, Beirut, Lebanon
ESO-ESMO-ABC guidelines in metastatic breast cancer ( Dr Nagi El Saghir - American University of Beirut, Beirut, Lebanon )
26 Jan 2018
ESMO 2017 roundup with Dr Bishal Gyawali (1/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
Celebrating a 10 year partnership: ecancer and the IEO
Prof Gordon McVie - Editor in Chief, ecancer
Celebrating a 10 year partnership: ecancer and the IEO ( Prof Gordon McVie - Editor in Chief, ecancer )
19 Jul 2017
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year
Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year ( Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy )
5 Jun 2017
Halving duration of ADT for high risk prostate cancer patients
Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Halving duration of ADT for high risk prostate cancer patients ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
4 Jun 2017
Delaying metastatic prostate cancer, improving survival with abiraterone
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Delaying metastatic prostate cancer, improving survival with abiraterone ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
3 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation